Loading clinical trials...
Loading clinical trials...
Study of Comparing Dexketoprofen to Placebo in Migraine Attack
H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.
Migraine attack is one of the most leading causes presentations to emergency department. Patients with migraine attack seek urgent care to cease their pain. There are so many interventions defined in the medical literature that can be used in migraine attacks. However, as a IV drug, dexketoprofen; little known whether IV dexketoprofen is superior to placebo or not. In the present study we aimed to determine the effects of IV dexketoprofen in migraine attack in emergency department.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Antalya Training and Govermental Hospital
Antalya, Turkey (Türkiye)
Start Date
May 1, 2014
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
July 23, 2015
224
ACTUAL participants
Dexketoprofen
DRUG
Normal Saline
OTHER
Lead Sponsor
Akdeniz University
NCT07018713
NCT06641466
NCT04715685
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions